Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would take into consideration new talks with insurers concerning the listing costs of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. Hear https://label-the-figure-with-the07384.blogzag.com/74809523/the-smart-trick-of-healthcare-news-that-nobody-is-discussing